|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,824.50 GBX | +0.19% |
|
+1.08% | +35.50% |
| 12-12 | US FDA approves Innoviva's oral antibiotic for gonorrhea | RE |
| 12-12 | Surprise UK GDP Contraction Keeps FTSE 100 in the Red | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 3.57% | 3.83% | 13.02x | 5.11x | 2.69x | 7.92x | 9.07x | 97.84B | ||
| 0.58% | 0.65% | 44.92x | 33.83x | 14.86x | 32.99x | 35.43x | 920B | ||
| 2.44% | 2.52% | 20.19x | 6.44x | 5.61x | 15.54x | 17.04x | 510B | ||
| 2.92% | 3.04% | 51.11x | 3046.66x | 7.4x | 17.52x | 18.03x | 395B | ||
| 3.12% | 3.18% | 18.38x | 6.56x | 4.62x | 11.57x | 13.11x | 340B | ||
| 1.8% | 1.89% | 27.04x | 6.1x | 5.12x | 15.2x | 15.98x | 278B | ||
| 3.08% | 3.21% | 18.3x | 5.73x | 4.95x | 11.64x | 12.54x | 254B | ||
| 3.22% | 3.26% | 12.96x | 4.66x | 4.23x | 9.08x | 10.21x | 249B | ||
| 3.62% | 3.55% | 13.93x | 7.56x | 4.98x | 10.31x | 11.91x | 224B | ||
| 3.01% | 3.19% | 25.04x | 18.93x | 5.94x | 10.2x | 13.63x | 171B | ||
| 2.75% | 2.87% | 17.56x | 6.56x | 5.55x | 10.14x | 12.2x | 149B | ||
| 6.6% | 6.73% | 13.38x | 1.63x | 3x | 7.56x | 8.71x | 147B | ||
| 4.99% | 5.17% | 12x | 1.3x | 2.61x | 8.48x | 9.43x | 119B | ||
| -.--% | -.--% | 29.11x | 6.14x | 8.81x | 19.02x | 19.76x | 115B | ||
| 4.72% | 4.83% | 12.35x | 5.36x | 2.91x | 8.43x | 8.85x | 107B | ||
| 2.97% | 1.52% | 32.81x | 7.14x | 10.6x | 20.74x | 22.18x | 90.26B | ||
| 0.44% | 0.5% | 47.71x | 6.98x | 11.51x | 37.88x | 39.84x | 59.5B | ||
| -.--% | -.--% | 174.32x | 62.8x | 13.6x | 89.8x | 87.05x | 52.52B | ||
| 4.5% | 4.57% | 39.95x | 1.02x | 2.43x | 9x | 25.91x | 45.11B | ||
| Average | 2.86% | 2.87% | 32.85x | 170.55x | 6.39x | 18.58x | 20.57x | 227.58B | |
| Weighted average by Cap. | 2.48% | 2.53% | 29.97x | 290.46x | 7.52x | 18.36x | 20.00x |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















